Skip to main content
    T

    Thermo Fisher Scientific Inc (TMO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $691.77
    -8.45 (-1.21%)

    Market Cap: $259.44B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Thermo Fisher Scientific Inc (TMO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Thermo Fisher Scientific (TMO) to earn $25.28 per share in the fiscal year ending Dec 31, 2026, on revenue of $48.01B. Of 27 analysts, 23 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 23 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 27 ratings average 2.11, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 85% of the ratings.

    RatingAnalystsShare
    Strong Buy311.1%
    Buy2074.1%
    Hold311.1%
    Sell00.0%
    Strong Sell13.7%
    Consensus
    Buy
    Total analysts
    27

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 9.9% and revenue estimates rise 5.3%.

    Fiscal year ending Dec 31, 2026
    $25.28
    EPS consensus, revenue $48.01B
    Fiscal year ending Dec 31, 2027
    $27.78
    EPS consensus, revenue $50.54B
    Next report
    Jan 27, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$25.28$25.15 to $25.4027$48.01B$47.85B to $48.22B25
    Dec 31, 2027$27.78$27.02 to $29.3127$50.54B$49.94B to $51.48B25

    Quarterly Estimates

    The EPS consensus falls from $7.19 for the quarter ending Dec 31, 2026 to $6.05 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$7.19$6.86 to $7.6223$12.98B$12.46B to $13.64B24
    Mar 31, 2027$6.05$5.64 to $6.5313$11.74B$11.60B to $11.98B11

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 49 upward and 8 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026231
    Fiscal year ending Dec 31, 2027204
    Quarter ending Mar 31, 202763

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.6% from $25.12.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$25.28$25.26$25.13$25.13$25.12+0.6%
    Fiscal year ending Dec 31, 2027$27.78$27.74$27.55$27.53$27.51+1.0%
    Quarter ending Mar 31, 2027$6.05$6.05$5.98$6.00$6.00+0.8%

    Frequently Asked Questions About TMO

    What is the TMO stock forecast?

    Consensus analyst estimates put Thermo Fisher Scientific's EPS at $25.28 for the fiscal year ending Dec 31, 2026, on revenue of $48.01B. The consensus rating from 27 analysts is Buy.

    How do analysts rate TMO stock?

    Of 27 analysts covering Thermo Fisher Scientific, 3 rate it Strong Buy, 20 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from TMO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $25.28, with estimates from $25.15 to $25.40 from 27 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $27.78, with estimates from $27.02 to $29.31 from 27 analysts.

    What revenue do analysts expect from Thermo Fisher Scientific next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $48.01B, with estimates from $47.85B to $48.22B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $50.54B, with estimates from $49.94B to $51.48B.

    How many analysts cover TMO?

    27 analysts rate Thermo Fisher Scientific stock, and 27 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.